N-乙酰色氨酸在心脏手术后急性肾损伤中的作用
该研究纳入2504例心脏手术患者,通过代谢组学发现N-乙酰色氨酸(NAT)在术后发生急性肾损伤(AKI)患者血浆中升高,并在多种小鼠肾损伤模型及上皮细胞模型中证实NAT具有肾脏保护作用,机制涉及与KEAP1的483和508位点相互作用,促进Nrf2核转位及蛋白酶体基因转录。
要点
- 心脏手术后AKI患者血浆NAT水平较未发生AKI者升高。
- NAT在缺血再灌注、顺铂及单侧输尿管梗阻诱导的肾损伤模型中显示保护作用。
- NAT通过作用于KEAP1的483和508位点激活Nrf2及蛋白酶体基因转录。
核心结论
- NAT在心脏手术后AKI中发挥关键肾脏保护作用。
研究设计与样本
- 共纳入2504例心脏手术后伴或不伴AKI的患者进行代谢组学分析。
- 基于1042例患者队列鉴定出32种与AKI发生相关的差异代谢物。
- 采用不同肾损伤小鼠模型及上皮细胞模型验证NAT功能。
主要发现
- 心脏手术后发生AKI患者血浆NAT水平高于未发生AKI者,并经靶向定量确认。
- NAT在缺血再灌注、顺铂及单侧输尿管梗阻诱导的小鼠肾损伤模型中表现出肾脏保护效应。
- NAT与KEAP1的483和508位点相互作用,分别导致Nrf2核转位和蛋白酶体基因转录。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
KEY POINTS: N-acetyl-tryptophan (NAT) was elevated in plasma of patients with cardiac surgery–associated AKI compared with those who do not develop AKI after surgery. NAT exhibited kidney-protective effects in ischemia-reperfusion–, cisplatin-, and unilateral ureteral obstruction–induced kidney injury mouse models and epithelial cellular models. NAT interacted with Kelch-like ECH-associated protein 1 at 483 and 508 sites, resulting in Nrf2 nuclear translocation and proteasome genes transcription, respectively. BACKGROUND: Cardiac surgery–associated AKI is a common serious complication after cardiac surgery. Currently, there are no specific pharmacological therapies. Our understanding of its pathophysiology remains preliminary. METHODS: A total of 2504 patients with and without AKI after cardiac surgery were enrolled. High-performance liquid chromatography coupled with mass spectrometry was used for untargeted analysis of metabolites in plasma, identifying significant differential metabolites. Subsequently, a liquid chromatography–tandem mass spectrometry–based approach using isotope-labeled standard addition was performed for targeted analysis of the metabolic marker N-acetyl-tryptophan (NAT). The function of NAT was determined using different kidney injury mouse models and epithelial cellular models. Transcriptome sequencing, surface plasmon resonance, and protein mutation were used to explore the mechanism of NAT on the kidney. RESULTS: We identified a total of 32 differential metabolites related to AKI occurrence on the basis of a cohort of 1042 patients. Among them, NAT was elevated in plasma of patients with cardiac surgery–associated AKI compared with those who did not develop AKI after cardiac surgery. The higher level of NAT in plasma was confirmed by accurate targeted quantification. NAT exhibited kidney-protective effects in ischemia-reperfusion–, cisplatin-, and unilateral ureteral obstruction–induced kidney injury mouse models. Mechanistically, NAT exerted kidney-protective effects by interacting with Kelch-like ECH-associated protein 1 at 483 and 508 sites, resulting in Nrf2 nuclear translocation and the transcription of proteasome genes, respectively. CONCLUSIONS: NAT plays a key role in kidney protection.
引用
- Shi N, Wang JW, Su G, et al. N -Acetyl-Tryptophan in Acute Kidney Injury after Cardiac Surgery. J Am Soc Nephrol. 2025. PMID: 39847454. doi:10.1681/ASN.0000000626
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。